Gracell Biotechnologies Inc. carries a market capitalization of 197.97M, placing it among publicly traded companies globally.
| Market Cap | 197.97M |
| Enterprise Value | N/A |
Gracell Biotechnologies Inc.'s stock has gained approximately 415.07538% over the past 52 weeks. The 50-day moving average sits at 9.13, while the 200-day moving average is 5.01.
| Beta (5Y) | N/A |
| 52-Week Price Change | 415.07538% |
| 50-Day Moving Average | 9.13 |
| 200-Day Moving Average | 5.01 |
| Average Volume (20 Days) | N/A |